The OncoAlert Weekly RoundUp September 12-18, 2025: PRIME | NECTIN-4 | PREOPANC-2 | WU-KONG1B & More

The OncoAlert Weekly Roundup is your go-to podcast for the latest, most impactful updates in oncology from across the globe 🌍. Each week, we break down the key studies shaping cancer care—so you stay ahead, in just minutes.

This week’s highlights include:
🔹 PRIME Diagnostic Trial: Bi-MRI vs. mp-MRI in #ProstateCancer
🔹 NECTIN4-CAR T cells show promise in #BladderCancer
🔹 Global consensus on bladder-sparing MIBC trial endpoints
🔹 PREOPANC-2 in resectable #PancreaticCancer
🔹 WU-KONG1B: Sunvozertinib in EGFR exon20 #NSCLC
🔹 Updated ASTRO–ASCO–SSO guideline on PMRT in #BreastCancer
🔹 Impact of sequential ADCs in HER2- MBC
🔹 Sacituzumab govitecan in low-grade serous #OvarianCancer
🔹 OlAnCa Trial: Olanzapine in cancer cachexia
🔹 Nurse-delivered Meaning-Centered Psychotherapy for advanced cancer

👉 Don’t miss an episode—subscribe now for concise, evidence-based insights that matter to your practice.
✨ Stay tuned. Stay informed. Stay #OncoAlert.